The Availability of Over-the-Counter Birth Control Pills: Your Guide to Accessing Opill

FDA approves nonprescription oral contraceptive, Opill, expected to hit stores in early 2024.

The Food and Drug Administration (FDA) has made a significant decision that is expected to greatly expand access to birth control in the United States. The FDA has approved the first nonprescription oral contraceptive, known as Opill, which will soon be available to millions of people. However, it's important to note that Opill will not be immediately available for sale, and there are still some details that need to be worked out.

According to a spokesperson for Perrigo Co., the manufacturer of Opill, the medication is expected to hit stores in "early 2024." Unfortunately, a more specific timeline for distribution has not been provided at this time.

Opill has been approved by the FDA to be sold over-the-counter, just like other medications such as Tylenol. This means that it will be available for purchase without a prescription. However, the exact placement of the product within stores will be up to the discretion of individual retailers. It is also up to the retailers to decide whether or not to lock the product behind anti-theft protection.

CVS and Walgreens, two major pharmacy chains in the US, have not yet revealed their plans for Opill. Dani Lynch, owner and pharmacist at Thrifty Pharmacy, intends to keep Opill behind the counter even though a prescription will not be required. She believes that this will encourage people, especially young individuals, to seek guidance and engage in conversations about birth control.

Pricing information for Opill has not been released by Perrigo, but the company plans to do so in the coming months before the product becomes available in stores. Perrigo is committed to ensuring that Opill is accessible and affordable to a wide range of individuals. They are also developing a consumer assistance program to help those who may struggle financially but would benefit from using Opill.

Opill will be sold at various locations, including drug stores, convenience stores, grocery stores, and online. Perrigo is still in the process of determining which specific retailers and online distributors they will partner with, and they will announce these partnerships in the near future.

Opill was initially approved by the FDA as a prescription birth control in 1973. It was marketed by Pfizer for over 30 years under the name Ovrette before being discontinued for business reasons. Opill, also known as a "mini-pill" due to its single hormone composition, has extensive safety and efficacy data. It has been found to be 93% effective in preventing pregnancy.

The FDA's approval of Opill has been celebrated by various medical groups and reproductive rights advocates. The American College of Obstetricians and Gynecologists considers it a significant advancement in reproductive healthcare accessibility, while the American Medical Association urges the FDA to approve more over-the-counter contraceptives. They believe that providing patients with a range of options for birth control is crucial.

In the meantime, over half of US states have laws that allow pharmacists to prescribe hormonal contraceptives, eliminating the need for a doctor's prescription. This has already increased access to birth control for many individuals.

Share With Others